MicroRNA‐mediated drug resistance in ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MicroRNA‐mediated drug resistance in ovarian cancer

Published:2017-07-14 Issue:4 Volume:234 Page:3180-3191
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

Mihanfar Aynaz¹²,Fattahi Amir³⁴,Nejabati Hamid Reza¹^ORCID

Affiliation:

1. Women's Reproductive Health Research CenterTabriz University of Medical SciencesTabrizIran

2. Faculty of Medicine, Department of BiochemistryUrmia University of Medical SciencesUrmiaIran

3. Faculty of Advanced Medical SciencesDepartment of Reproductive BiologyTabriz University of Medical SciencesTabrizIran

4. Department of Obstetrics and Gynecology, Erlangen University HospitalFriedrich‐Alexander University Erlangen‐NurembergErlangenGermany

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.26060

Reference109 articles.

1. DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma

2. miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies

3. Stem and Progenitor-Like Cells Contribute to the Aggressive Behavior of Human Epithelial Ovarian Cancer

4. Reversion of P-gp-Mediated Drug Resistance in Ovarian Carcinoma Cells with PHPMA-Zosuquidar Conjugates

5. Epigenetic regulation of the MGMT and hMSH6 DNA repair genes in cells resistant to methylating agents;Bearzatto A.;Cancer Research,2000

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Network pharmacology and experimental methods to explore the mechanism of Guizhi Fuling capsule in overcoming cisplatin-resistant ovarian cancer;2024-08-27

2. H2O2 promotes photodynamic efficacy of TMPyP4 against ovarian cancer in vitro by downregulating HIF-1α expression;Biomedicine & Pharmacotherapy;2024-08

3. Development of an efficient liposomal DOX delivery formulation for HCC therapy by targeting CK2α;Biotechnology Journal;2024-04

4. Drug resistance in ovarian cancer: from mechanism to clinical trial;Molecular Cancer;2024-03-28

5. MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies;Experimental & Molecular Medicine;2023-07-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3